More on Ocera Q2 results


Ocera Therapeutics (OCRX -1%) Q2 results: Revenues: $33K; Net Loss: ($7.2M) (-246.1%); Loss Per Share: ($0.46) (+85.8%); Quick Assets: $38.1M (-19.3%).

2014 Guidance: Cash burn: $30M; quick assets on hand sufficient to fund operations through 2016.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs